Reliance Global Group Provides Update on Enquantum Private 5G Deployment and Smart Infrastructure Initiatives Posted on May 18, 2026
Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments Posted on May 7, 2026
Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call Posted on May 6, 2026
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment Posted on May 5, 2026
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division Posted on May 4, 2026